A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis

Clinical trial NCT07051538 · COMPLETED

Trial details

NCT number: NCT07051538
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate to Severe Plaque Psoriasis

Start date: 2024-06-26
Primary completion: 2025-11-28
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.